Exact Mass: 273.1576148
Exact Mass Matches: 273.1576148
Found 471 metabolites which its exact mass value is equals to given mass value 273.1576148,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
beta-Erythroidine
C16H19NO3 (273.13648639999997)
An organic heterotetracyclic indole alkaloid isolated from the seeds and other parts of Erythrina species. It differs from the alpha isomer in having the double bond of the dihydropyranone ring located beta,gamma- to the lactone carbonyl group instead of alpha,beta-.
8-Allyl-2-phenyl-8H-1,3a,8-triaza-cyclopenta[a]indene
Norgalantamine
C16H19NO3 (273.13648639999997)
N-Desmethyl Galanthamine is a metabolite of Galanthamine. Galanthamine is a potent acetylcholinesterase (AChE) inhibitor with an IC50 of 500 nM[1][2].
Sanguinine
C16H19NO3 (273.13648639999997)
Sanguinine is a benzazepine. Sanguinine is a natural product found in Lycoris sanguinea, Lycoris squamigera, and other organisms with data available. O-Desmethyl Galanthamine (Sanguinine) is galanthamine-type alkaloid. O-Desmethyl Galanthamine is an acetylcholinesterase (AChE) inhibitor, with an IC50 1.83 μM[1].
4-O-Methylnorbelladine
C16H19NO3 (273.13648639999997)
A phenethylamine alkaloid that is norbelladine in which the phenolic hydrogen at position 4 has been replaced by a methyl group.
(E,E)-Piperlonguminine
C16H19NO3 (273.13648639999997)
(E,E)-Piperlonguminine is a member of benzodioxoles. Piperlonguminine is a natural product found in Piper amalago, Piper retrofractum, and other organisms with data available. (E,E)-Piperlonguminine is found in herbs and spices. (E,E)-Piperlonguminine is an alkaloid from Piper longum (long pepper) and other Piper specie Alkaloid from Piper longum (long pepper) and other Piper subspecies (E,E)-Piperlonguminine is found in herbs and spices. Piperlonguminine is an alkaloid amide isolated from the Piper species. Piperlonguminine shows various biological properties, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, antifungal and antibacterial activities[1][2][3][4]. Piperlonguminine is an alkaloid amide isolated from the Piper species. Piperlonguminine shows various biological properties, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, antifungal and antibacterial activities[1][2][3][4].
(2E)-Piperamide-C5:1
C16H19NO3 (273.13648639999997)
(2E)-Piperamide-C5:1 is found in herbs and spices. (2E)-Piperamide-C5:1 is a constituent of pepper fruits (Piper nigrum, Piperaceae). Constituent of pepper fruits (Piper nigrum, Piperaceae). (2E)-Piperamide-C5:1 is found in herbs and spices and pepper (spice).
Valylarginine
C11H23N5O3 (273.18008080000004)
Valylarginine is a dipeptide composed of valine and arginine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Arginylvaline
C11H23N5O3 (273.18008080000004)
Arginylvaline is a dipeptide composed of arginine and valine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Glutaconylcarnitine
Glutaconylcarnitine is an acylcarnitine. More specifically, it is an glutaconic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Glutaconylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine glutaconylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. A human metabolite taken as a putative food compound of mammalian origin [HMDB]
Heptanoylcarnitine
Heptanoylcarnitine is an acylcarnitine. More specifically, it is an heptanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Heptanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine heptanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. A human metabolite taken as a putative food compound of mammalian origin [HMDB]
Linalyl anthranilate
Linalyl anthranilate is used in food flavourin It is used in food flavouring.
alpha-Terpinyl anthranilate
alpha-Terpinyl anthranilate is a flavouring ingredient with a complex fruity odour and bitter taste. Flavouring ingredient with a complex fruity odour and bitter taste
N-Despropyl-rotigotine
N-Despropyl-rotigotine is a metabolite of rotigotine. Rotigotine (Neupro) is a non-ergoline dopamine agonist indicated for the treatment of Parkinsons disease (PD) and restless legs syndrome (RLS) in Europe and the United States. It is formulated as a once-daily transdermal patch which provides a slow and constant supply of the drug over the course of 24 hours. Like other dopamine agonists, rotigotine has been shown to possess antidepressant effects and may be useful in the treatment of depression as well. (Wikipedia)
N-Acetyl desmethyl frovatriptan
C15H19N3O2 (273.14771939999997)
N-Acetyl desmethyl frovatriptan is a metabolite of frovatriptan. Frovatriptan (trade name Frova) is a triptan drug developed by Vernalis for the treatment of migraine headaches and for short term prevention of menstrual migraine. The product is licensed to Endo Pharmaceuticals in North America and Menarini in Europe. (Wikipedia)
4-Methylhexanoylcarnitine
4-Methylhexanoylcarnitine is an acylcarnitine. More specifically, it is an 4-methylhexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Methylhexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-Methylhexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
5-Methylhexanoylcarnitine
5-Methylhexanoylcarnitine is an acylcarnitine. More specifically, it is an 5-methylhexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Methylhexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Methylhexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
3-Methylhexanoylcarnitine
3-Methylhexanoylcarnitine is an acylcarnitine. More specifically, it is an 3-methylhexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Methylhexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-Methylhexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(3E)-Glutaconylcarnitin
(3E)-Glutaconylcarnitin is an acylcarnitine. More specifically, it is an (3E)-pent-3-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (3E)-Glutaconylcarnitin is therefore classified as a short chain AC. As a short-chain acylcarnitine (3E)-Glutaconylcarnitin is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(4E)-3-Hydroxyhex-4-enoylcarnitine
(4E)-3-hydroxyhex-4-enoylcarnitine is an acylcarnitine. More specifically, it is an (4E)-3-hydroxyhex-4-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4E)-3-hydroxyhex-4-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (4E)-3-hydroxyhex-4-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
3-Oxohexanoylcarnitine
3-oxohexanoylcarnitine is an acylcarnitine. More specifically, it is an 3-oxohexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-oxohexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-oxohexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
5-Oxohexanoylcarnitine
5-oxohexanoylcarnitine is an acylcarnitine. More specifically, it is an 5-oxohexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-oxohexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-oxohexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
Hhcfu
C11H16FN3O4 (273.11247879999996)
Desmethylcyproheptadine
Mopidralazine
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent
N-Desmethyl zolmitriptan
C15H19N3O2 (273.14771939999997)
Norgalanthamine
C16H19NO3 (273.13648639999997)
Prodolic acid
C16H19NO3 (273.13648639999997)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids
indole-3-acetyl-valine
Indole-3-acetyl-valine is also known as iaa-val. Indole-3-acetyl-valine is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Indole-3-acetyl-valine can be found in a number of food items such as avocado, cupua√ßu, green bean, and guava, which makes indole-3-acetyl-valine a potential biomarker for the consumption of these food products. Indole-3-acetyl-valine is also known as iaa-val. Indole-3-acetyl-valine is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Indole-3-acetyl-valine can be found in a number of food items such as avocado, cupuaçu, green bean, and guava, which makes indole-3-acetyl-valine a potential biomarker for the consumption of these food products.
Valyl-Arginine
C11H23N5O3 (273.18008080000004)
4,8-dimethoxy-3-(3-methylbut-2-enyl)-1H-quinolin-2-one
C16H19NO3 (273.13648639999997)
8-(gamma,gamma-dimethylallyloxy)-4-methoxy-N-methyl-2-quinolone
C16H19NO3 (273.13648639999997)
metazachlor OXA
A monocarboxylic acid that is oxoacetic acid substituted by a (2,6-dimethylphenyl)(1H-pyrazol-1-ylmethyl)amino group at position 2. It is metabolite of the herbicide metazachlor. CONFIDENCE standard compound; EAWAG_UCHEM_ID 706 CONFIDENCE standard compound; INTERNAL_ID 2062
Ethyl 2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics N - Nervous system > N02 - Analgesics > N02A - Opioids
10-Methoxy-3,12-didehydrogalanthan-1,9-diol #
C16H19NO3 (273.13648639999997)
8-O-demethylmaritidine|9-O-Demethylmaritidine
C16H19NO3 (273.13648639999997)
4-O-Demethylmesembrenon|4-O-Demethylmesembrenone
C16H19NO3 (273.13648639999997)
1,2-O-Isopropylidene,N,5-Di-Ac-alpha-D-Furanose-3-Amino-3-deoxyribose
(2E,4E,6E)-7-(2-thienyl)-2,4-6-heptatrienoic acid piperidide|1-[(2E,4E,6E)-1-oxo-7-(2-thienyl)heptatrienyl]piperidine|1-[(2E,4E,6E)-7-(2-thienyl)-2,4,6-heptatrienoyl]piperidine|7-(thiophene)-2E,4E,6E-heptatrienoic acid piperidide|N-piperidineotanthusic acid amide|Otanthus acid piperidide|Otanthus Maritima amide|Otanthussaeure-piperidid
6-(4-methoxyphenyl)-N-(2-methylpropyl)hexa-2,4-dienamide
3-(1-hydroxyethyl)-6-(indol-3-ylmethyl)-2,5-diketopiperazine|cyclo(L-Trp-L-Ser-)|cyclo(L-tryptophanyl-L-seryl)|cyclo-L-Trp-L-Ser
(-)-2-Isopropyl-6-methoxy-5-methyl-3,5-dihydro-2H-furo[3,2-c]chinolin-4-on|(-)-2-isopropyl-6-methoxy-5-methyl-3,5-dihydro-2H-furo[3,2-c]quinolin-4-one|2.3.4.5-tetrahydro-2-isopropyl-6-methoxy-5-methyl-4-oxo-furano<3.2-c>chinolin
C16H19NO3 (273.13648639999997)
(8aS,9R,11R,12aS)-6,7,8,8a,9,10,11,12-octahydro-8a-hydroxy-11-methyl-1,9-ethanobenzo[i]quinolizin-13,14-dione|huperzine F
C16H19NO3 (273.13648639999997)
N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]-2-methylpropanamide
(1S,1R)-1-hydroxy-4-(2,6-dideoxy-beta-D-xylo-hexapyranosyloxy)-2-cyclopentene-1-carboxamide
N-[2-(2,2-Dimethyl-2H-1-benzopyran-6-yl)ethyl]butanamide
Norgalantamine
Norgalanthamine is a benzazepine. Norgalanthamine is a natural product found in Lycoris squamigera, Hymenocallis rotata, and other organisms with data available. N-Desmethyl Galanthamine is a metabolite of Galanthamine. Galanthamine is a potent acetylcholinesterase (AChE) inhibitor with an IC50 of 500 nM[1][2].
Tilidine
N - Nervous system > N02 - Analgesics > N02A - Opioids CONFIDENCE standard compound; EAWAG_UCHEM_ID 3329
NVE_274.1802_16.6
CONFIDENCE Tentative identification: most likely structure (Level 3); INTERNAL_ID 1207
4-hydroxy-2-octylquinoline 1-oxide:Series 4 HAQ C8
(E,E)-Piperlonguminine; AIF; CE0; CorrDec
C16H19NO3 (273.13648639999997)
(E,E)-Piperlonguminine; AIF; CE10; CorrDec
C16H19NO3 (273.13648639999997)
(E,E)-Piperlonguminine; AIF; CE30; CorrDec
C16H19NO3 (273.13648639999997)
(E,E)-Piperlonguminine; AIF; CE0; MS2Dec
C16H19NO3 (273.13648639999997)
(E,E)-Piperlonguminine; AIF; CE10; MS2Dec
C16H19NO3 (273.13648639999997)
(E,E)-Piperlonguminine; AIF; CE30; MS2Dec
C16H19NO3 (273.13648639999997)
Arg-val
C11H23N5O3 (273.18008080000004)
A dipeptide formed from L-arginine and L-valine residues.
Val-arg
C11H23N5O3 (273.18008080000004)
A dipeptide formed from L-valine and L-asparagine residues.
piperlonguminine
C16H19NO3 (273.13648639999997)
Piperlonguminine is an alkaloid amide isolated from the Piper species. Piperlonguminine shows various biological properties, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, antifungal and antibacterial activities[1][2][3][4]. Piperlonguminine is an alkaloid amide isolated from the Piper species. Piperlonguminine shows various biological properties, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, antifungal and antibacterial activities[1][2][3][4].
Piperamide-C5:1 (2E)
C16H19NO3 (273.13648639999997)
1-(p-Methoxyphenyl)-5-piperidino-1-penten-3-one
5-TRIFLUOROMETHYLPYRIDINE-2-BORONIC ACID PINACOL ESTER
ethyl 5-tert-butyl-3-formyl-1H-indole-2-carboxylate
C16H19NO3 (273.13648639999997)
(R)-2-((TERT-BUTOXYCARBONYL)AMINO)-2-((1R,4R)-4-HYDROXYCYCLOHEXYL)ACETIC ACID
2-N-BOC-Amino-3-(4-tetrahydropyranyl)-propionsaeure
3-(6-ethyl-7-methoxy-5-methylimidazo[1,2-a]pyrimidin-2-yl)-5-methyl-1,2,4-oxadiazole
5-ALLYLOXY-3,6-DIHYDRO-2H-PYRIDINE-1-CARBOXYLIC ACID BENZYL ESTER
C16H19NO3 (273.13648639999997)
4-[3-(1,3-BENZODIOXOL-5-YL)-1,2,4-OXADIAZOL-5-YL]PIPERIDINE
Tricyclo[3.3.1.13,7]decane, 1-(4-nitrophenyl)
C16H19NO3 (273.13648639999997)
5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2-(TRIFLUOROMETHYL)PYRIDINE
7-Chloro-2-[[[(1S)-2,2-dimethylcyclopropyl]carbonyl]amino]-2-heptenoic acid
4-ALLYL-5-(4-TERT-BUTYLPHENYL)-4H-1,2,4-TRIAZOLE-3-THIOL
BENZYL 4-OXO-2-PROPYL-3,4-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE
C16H19NO3 (273.13648639999997)
BENZYL 2-ISOPROPYL-4-OXO-3,4-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE
C16H19NO3 (273.13648639999997)
(2S)-2,3,3-trideuterio-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(2,3,4,5,6-pentadeuteriophenyl)propanoic acid
3,4-DIHYDRO-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)ISOQUINOLIN-1(2H)-ONE
C15H20BNO3 (273.15361600000006)
2-{[1-(tert-Butoxycarbonyl)-4-piperidinyl]-oxy}propanoic acid
2-(1,4-dioxaspiro[4.5]decan-8-yl)-1,2,3,4-tetrahydroisoquinoline
3-methoxycarbonylmethoxy-piperidine-1-carboxylic acid tert-butyl ester
1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyrrolidine
(S)-MORPHOLINE-3,4-DICARBOXYLICACID4-TERT-BUTYLESTER
5-Trifluoromethylpyridine-3-boronic acid pinacol ester
N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)cyclopropanamine
(S)-tert-Butyl 3-(2-ethoxy-2-oxoethyl)morpholine-4-carboxylate
(R)-TERT-BUTYL 4-(4-HYDROXYBUTYL)-2,2-DIMETHYLOXAZOLIDINE-3-CARBOXYLATE
4-(2-cyclohexylethylamino)-2-nitrobenzonitrile
C15H19N3O2 (273.14771939999997)
1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridinone
C15H19N3O2 (273.14771939999997)
2-Trifluoromethylpyridine-4-boronic acid pinacol ester
Naphazoline nitrate
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D019141 - Respiratory System Agents > D014663 - Nasal Decongestants D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents Naphazoline (Naphthazoline) nitrate is an α-adrenergic receptor agonist. Naphazoline nitrate reduces vascular hyperpermeability and promotes vasoconstriction. Naphazoline nitrate reduces the levels of inflammatory factors (TNF-α, IL-1β and IL-6), cytokines (IFN-γ and IL-4), IgE, GMCSF, and NGF。Naphazoline nitrate can be used for non-bacterial conjunctivitis research[1][2].
(1R,4R)-1-(AMINOMETHYL)-4-(4-FLUOROBENZYL)CYCLOHEXANOL HYDROCHLORIDE
C14H21ClFNO (273.12956180000003)
3-(Boc-amino)-3-(4-tetrahydropyranyl)propanoic Acid
1-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PYRROLIDINE
(R)-2-(diphenylmethyl)pyrrolidine hydrochloride
C17H20ClN (273.12841900000006)
tert-butyl 4,4-bis(2-hydroxyethyl)piperidine-1-carboxylate
1-BOC-4-(METHOXYCARBONYL)PYRROLIDINE-3-CARBOXYLIC ACID
6-PHENETHYLCARBAMOYL-CYCLOHEX-3-ENECARBOXYLIC ACID
C16H19NO3 (273.13648639999997)
(4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate
ETHYL 2-ISOPROPOXY-4-METHOXYBENZIMIDATE HYDROCHLORIDE
4,4-Diphenylpiperidine hydrochloride
C17H20ClN (273.12841900000006)
tert-Butyl 4-methoxynaphthalen-2-ylcarbamate
C16H19NO3 (273.13648639999997)
1-Methyl-1-propylpyrrolidinium hexafluorophosphate
2-Fluoro-4-(trans-4-pentylcyclohexyl)-benzonitrile
1-Piperidinecarboxylic acid, 4-(1H-pyrrolo[2,3-b]pyridin-3-yl)-, ethyl ester
C15H19N3O2 (273.14771939999997)
3-(3-CYCLOPROPYL-1-OXOPROPYL)-4(R)-(1-PHENYLMETHYL)-2-OXAZOLIDINONE
C16H19NO3 (273.13648639999997)
2-Amino-8-benzyl-2,8-diazaspiro[4.5]decane-1,3-dione
C15H19N3O2 (273.14771939999997)
4-Methyl 1-(2-methyl-2-propanyl) 4-methoxy-1,4-piperidinedicarbox ylate
ethyl prop-2-enoate,N-(hydroxymethyl)prop-2-enamide,prop-2-enoic acid
tert-butyl N-[2-(2,4-difluorophenyl)-2-hydroxyethyl]carbamate
3-[(4-methylpiperazin-1-yl)methyl]-5-(trifluoromethyl)aniline
2-CARBOXYMETHYL-5,5-DIMETHYL-MORPHOLINE-4-CARBOXYLIC ACID TERT-BUTYL ESTER
8-Hydroxy-1,1,7,7-tetramethyljulolidine-9-carboxaldehyde
N-Cbz-9-azabicyclo[3.3.1]nonan-3-one
C16H19NO3 (273.13648639999997)
3-Amino-6-(4-methylphenyl)pyrazinecarboxylicacidethylester-4-oxide
Oxaflozane
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants
(4S,trans)-1,1-Dimethylethyl-6-aminoethyl-2,2-dimethyl-1,3-dioxane-4-acetate
2-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl]-1,3,4-oxadiazole
Propanamide, 2-methyl-N-[2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethyl]
1-[3-(4-p-tolyl-piperazin-1-yl)-azetidin-1-yl]-ethanone
6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1H-qu inolin-2-one
C15H20BNO3 (273.15361600000006)
(2S)-1-TERT-BUTYL 2-ETHYL 5-METHOXYPYRROLIDINE-1,2-DICARBOXYLATE
2-(TERT-BUTYL)-7-HYDRAZINO-5-(TRIFLUOROMETHYL)PYRAZOLO[1,5-A]PYRIMIDINE
C11H14F3N5 (273.12012400000003)
5-diethylaminomethyl-2-phenyl-furan-3-carboxylic acid
C16H19NO3 (273.13648639999997)
(N-AcrylaMidophenyl)boronic acid pinacol ester
C15H20BNO3 (273.15361600000006)
(3aS,5R,6S,6aS)-[6-hydroxy-2,2-dimethyltetrahydrofuro[3,2-d][1,3]dioxol-5-yl]-(morpholino)methanone
6-(trifluoromethyl)pyridine-2-boronic acid pinacol ester
[2-(3,4-DIFLUOROPHENYL)-2-HYDROXYETHYL]-CARBAMIC ACID 1,1-DIMETHYLETHYL ESTER
Mavacamten
C15H19N3O2 (273.14771939999997)
C - Cardiovascular system > C01 - Cardiac therapy
Viloxazine hydrochloride
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018759 - Adrenergic Uptake Inhibitors C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents D049990 - Membrane Transport Modulators
7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinolin-1(2H)-one
C15H20BNO3 (273.15361600000006)
6-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
C15H20BNO3 (273.15361600000006)
4-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
C15H20BNO3 (273.15361600000006)
7-methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
C15H20BNO3 (273.15361600000006)
2-methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2,3,4-tetrahydroisoquinoline
N-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acrylamide
C15H20BNO3 (273.15361600000006)
D-ASPARTIC ACID, N-[(1,1-DIMETHYLETHOXY)CARBONYL]-, 4-(2-PROPENYL) ESTER
4-[2-(Methyl-2-pyridinyl)amino]ethoxyl nitrobenzene
2-METHYL-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE
3-(4-Benzyloxyphenoxy)-2-hydroxypropanamine
C16H19NO3 (273.13648639999997)
1-[(tert-butoxy)carbonyl]-3-(ethoxycarbonyl)azetidine-3-carboxylic acid
5-Methoxy-1H-indole-2-boronic acid pinacol ester
C15H20BNO3 (273.15361600000006)
1-[3-amino-5-[4-(tert-butyl)phenyl]-2-thienyl]ethan-1-one
2-{4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}ethanamine
4-(4-Methylpiperazin-1-ylmethyl)-3-trifluoromethylaniline
2-oxo-7-aza-spiro[3.5]nonane-7-carboxylic acid benzyl ester
C16H19NO3 (273.13648639999997)
1-(2-Ethoxy-ethyl)-2-piperidin-4-yl-1H-benzimidazole
Dextilidine
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics N - Nervous system > N02 - Analgesics > N02A - Opioids
s-Triazine, 1,2-dihydro-1-(p-butylphenyl)-4,6-diamino-2,2-dimethyl-
Tilidine, (-)-
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics N - Nervous system > N02 - Analgesics > N02A - Opioids
Tropanserin
C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist Tropanserin is a serotoninergic active compound, as well as a 5HT3 receptor antagonist. Tropanserin modulates Cardio-respiratory reflex effects of an exogenous serotonin challenge[1].
N-[2-[hydroxy(nitroso)amino]-3-methylbutyl]octanamide
C13H27N3O3 (273.20523119999996)
(E)-1-(4-methylphenyl)-3-quinolin-6-ylprop-2-en-1-one
1-Butyl-3-(2-hydroxyethylamino)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile
Evaclin; Evadol; Isodianidylethanolamine; LC 2
C16H19NO3 (273.13648639999997)
5-(1,3-Benzodioxol-5-yl)-N,N-diethyl-2,4-pentadienamide
C16H19NO3 (273.13648639999997)
N-{[(2s,3s)-3-(Ethoxycarbonyl)oxiran-2-Yl]carbonyl}-L-Isoleucine
3-Amino-3-benzyl-9-carboxamide[4.3.0]bicyclo-1,6-diazanonan-2-one
C15H19N3O2 (273.14771939999997)
5-Acetamido-5,6-Dihydro-4-Hydroxy-6-Isobutoxy-4h-Pyran-2-Carboxylic Acid
Prodolic acid
C16H19NO3 (273.13648639999997)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids
5950-12-9
C16H19NO3 (273.13648639999997)
Piperlonguminine is an alkaloid amide isolated from the Piper species. Piperlonguminine shows various biological properties, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, antifungal and antibacterial activities[1][2][3][4]. Piperlonguminine is an alkaloid amide isolated from the Piper species. Piperlonguminine shows various biological properties, including anti-inflammatory, antitumor, neuroprotective, anti-platelet, anti-melanogenic, antifungal and antibacterial activities[1][2][3][4].
4-(4-Cyclohexylanilino)-4-oxobut-2-enoic acid
C16H19NO3 (273.13648639999997)
N-[2-(cyclohex-1-en-1-yl)-2-(4-methoxyphenyl)ethyl]acetamide
4-Methoxy-9-azatetracyclo[7.5.2.01,10.02,7]hexadeca-2,4,6,13-tetraene-5,12-diol
C16H19NO3 (273.13648639999997)
N(2)-(3-carboxylatopropionyl)-L-arginine(1-)
An N-acyl-L-alpha-amino acid anion that is the conjugate base of N(2)-succinyl-L-arginine, arising from deprotonation of the carboxy groups and protonation of the amino group; major species at pH 7.3.
Methylglutaconyl hydroxy ornithine
C11H17N2O6- (273.10865620000004)
L-alanyl-(2S,3E)-amino-4-methoxy-but-3-enoyl-L-alanine
(2S,3S,7R)-2,3-diamino-8-(2-amino-4,5-dihydro-1H-imidazol-5-yl)-7-hydroxyoctanoic acid
C11H23N5O3 (273.18008080000004)
(2S)-2-[[(E,2S)-2-[[(2S)-2-aminopropanoyl]amino]-4-methoxybut-3-enoyl]amino]propanoic acid
8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3,5-dimethylbenzoate
2-[[1-(4-Ethoxyphenyl)-2,5-dioxo-3-pyrrolidinyl]amino]acetonitrile
1-(3-Pyridin-4-yl-4-oxa-1,2-diaza-spiro[4.6]undec-2-en-1-yl)-ethanone
C15H19N3O2 (273.14771939999997)
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1,5-dimethyl-4-pyrazolecarboxamide
N-[[(cyclohexylamino)-sulfanylidenemethyl]amino]carbamic acid tert-butyl ester
4-[(2-Methoxy-1-naphthalenyl)methyl]thiomorpholine
O-glutaconyl-L-carnitine
An O-acyl-L-carnitine where the acyl group specified is glutaconyl.
3-[1-(pentylamino)ethylidene]-3,4-dihydro-2H-1-benzopyran-2,4-dione
C16H19NO3 (273.13648639999997)
1-methyl-3-(6,7,8,9-tetrahydro-5H-carbazol-3-ylmethyl)thiourea
1-[2-[2-(2,3-dihydro-1H-inden-5-yloxy)ethoxy]ethyl]-1,2,4-triazole
C15H19N3O2 (273.14771939999997)
4-(2,4-dimethoxyphenyl)-3-methyl-4,5-dihydro-2H-pyrrolo[3,4-c]pyrazol-6-one
N-methyl-3-[3-(4-propan-2-ylphenyl)-1,2,4-oxadiazol-5-yl]propanamide
C15H19N3O2 (273.14771939999997)
(4-Tert-butylphenyl) 3,5-dimethyl-1,2-oxazole-4-carboxylate
C16H19NO3 (273.13648639999997)
(3R,8Z,11S)-11-methyl-3-phenyl-1-oxa-4-azacyclododec-8-en-12-one
O-glutaconylcarnitine
An O-acylcarnitine in which the acyl group specified is glutaconyl.
(E)-5-acetyl-3-(1-(2,2-dimethylhydrazineyl)propylidene)indolin-2-one
C15H19N3O2 (273.14771939999997)
(2E)-7-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]hept-2-enoate
(E,6R)-6-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyhept-2-enoate
[(2S)-1-(1H-indol-3-yl)-4-methyl-3-oxopentan-2-yl] acetate
C16H19NO3 (273.13648639999997)
3-[3-(4-Acetamidobutylamino)propylamino]-3-oxopropanoic acid
3-[4-(3-Acetamidopropylamino)butylamino]-3-oxopropanoic acid
N-Trimethylsilylpiperidine-4-carboxylic acid trimethylsilyl ester
1-(Trimethylsilyl)-3-piperidinecarboxylic acid trimethylsilyl ester
O-heptanoylcarnitine
An O-acylcarnitine that is the O-heptanoyl derivative of carnitine.
tropanyl 3,5-dimethylbenzoate
A tropane alkaloid that consists of tropine in which the hydrogen of the hydroxy function is substituted by a 3,5-dimethylbenzoyl group.
oscr#7(1-)
A hydroxy fatty acid ascaroside anion resulting from the deprotonation of the carboxy group of oscr#7. The conjugate base of oscr#7 and the major species at pH 7.3.
1-[(3r)-2,3-dihydroxy-5-(3-methylbut-2-en-1-yl)indol-3-yl]propan-2-one
C16H19NO3 (273.13648639999997)
5-(2h-1,3-benzodioxol-5-yl)-1-(pyrrolidin-1-yl)pent-2-en-1-one
C16H19NO3 (273.13648639999997)
9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl 2-phenylacetate
C16H19NO3 (273.13648639999997)
(1r,10r,12s)-4-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-5,12-diol
C16H19NO3 (273.13648639999997)
4-{2-[(5-methoxy-2-methylcyclohex-2-en-1-yl)(methyl)amino]ethenyl}phenol
(2r)-2-(2-methoxypropan-2-yl)-9-methyl-2h,3h-furo[2,3-b]quinolin-4-one
C16H19NO3 (273.13648639999997)
4-methoxy-1-methyl-3-(3-methyl-2-oxobutyl)quinolin-2-one
C16H19NO3 (273.13648639999997)
(10s,12s)-5-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-4,12-diol
C16H19NO3 (273.13648639999997)
(2e,4e)-6-(4-methoxyphenyl)-n-(2-methylpropyl)hexa-2,4-dienimidic acid
5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-trien-15-ol
C16H19NO3 (273.13648639999997)
(1s,15r,16r)-4-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraene-5,15-diol
C16H19NO3 (273.13648639999997)
5,14-dimethyl-5-azatetracyclo[7.7.0.0¹,¹².0³,⁸]hexadec-14-ene-10,16-dione
(3e)-4-{2-[(1e)-3-hydroxyhex-1-en-1-yl]-4-methylphenyl}but-3-enimidic acid
(2z,4z)-5-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)penta-2,4-dienimidic acid
C16H19NO3 (273.13648639999997)
(3e,5e)-6-(4-methoxyphenyl)-n-(2-methylpropyl)hexa-3,5-dienimidic acid
(1s,15r,16s)-5-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraene-4,15-diol
C16H19NO3 (273.13648639999997)
1-[(2r,6s)-6-[(2s)-2-hydroxy-2-phenylethyl]-1-methyl-5,6-dihydro-2h-pyridin-2-yl]propan-2-one
3-[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]-4-methoxy-1-methylquinolin-2-one
C16H19NO3 (273.13648639999997)
2-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadeca-7,9-diene-11,12-dione
C16H19NO3 (273.13648639999997)
(2e,4e,6e)-1-(piperidin-1-yl)-7-(thiophen-2-yl)hepta-2,4,6-trien-1-one
4-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-5,12-diol
C16H19NO3 (273.13648639999997)
(1s,14r)-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6(17),7,9,15-tetraene-9,14-diol
C16H19NO3 (273.13648639999997)
16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-trien-4-one
C16H19NO3 (273.13648639999997)
3-[(2e)-but-2-en-1-yl]-4-ethoxy-8-hydroxy-1-methylquinolin-2-one
C16H19NO3 (273.13648639999997)
(3e)-4-[4-methyl-2-(3-oxohexyl)phenyl]but-3-enimidic acid
(1r,10s,12r)-4-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-5,12-diol
C16H19NO3 (273.13648639999997)
(1s,15r,16s)-4-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraene-5,15-diol
C16H19NO3 (273.13648639999997)
(1r,9s,10r,13s,14r,16s)-14-methyl-11-oxa-5-azapentacyclo[7.4.3.1¹⁰,¹³.0¹,¹⁶.0⁵,¹⁶]heptadec-3-ene-2,12-dione
C16H19NO3 (273.13648639999997)
2-(2-methoxypropan-2-yl)-9-methyl-2h,3h-furo[2,3-b]quinolin-4-one
C16H19NO3 (273.13648639999997)
4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6(17),7,9,15-tetraene-9,14-diol
C16H19NO3 (273.13648639999997)
n-[2-(2,2-dimethylchromen-6-yl)ethyl]-2-methylpropanimidic acid
3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-4-methoxy-1-methylquinolin-2-one
C16H19NO3 (273.13648639999997)
(1s,3s,8s,9r,12s)-5,14-dimethyl-5-azatetracyclo[7.7.0.0¹,¹².0³,⁸]hexadec-14-ene-10,16-dione
(1s,13s,15r)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-trien-15-ol
C16H19NO3 (273.13648639999997)
n-[(2s)-2-[hydroxy(nitroso)amino]-3-methylbutyl]octanimidic acid
C13H27N3O3 (273.20523119999996)
5-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-4,12-diol
C16H19NO3 (273.13648639999997)
(1r,2r,3r,5s)-2-benzyl-8-methyl-8-azabicyclo[3.2.1]octan-3-yl acetate
(1r,13r,15s)-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9-trien-15-ol
C16H19NO3 (273.13648639999997)
14-methyl-11-oxa-5-azapentacyclo[7.4.3.1¹⁰,¹³.0¹,¹⁶.0⁵,¹⁶]heptadec-3-ene-2,12-dione
C16H19NO3 (273.13648639999997)
4-[(1z)-2-{[(1s,5s)-5-methoxy-2-methylcyclohex-2-en-1-yl](methyl)amino}ethenyl]phenol
2-benzyl-8-methyl-8-azabicyclo[3.2.1]octan-3-yl acetate
(1r,10s,12s)-5-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-4,12-diol
C16H19NO3 (273.13648639999997)
1-(1h-indol-3-yl)-4-methyl-3-oxopentan-2-yl acetate
C16H19NO3 (273.13648639999997)
4-methoxy-1-methyl-8-[(3-methylbut-2-en-1-yl)oxy]quinolin-2-one
C16H19NO3 (273.13648639999997)
4-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}butanoic acid
4-methoxy-9-azatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-2(7),3,5,12-tetraene-5,15-diol
C16H19NO3 (273.13648639999997)
5-(2h-1,3-benzodioxol-5-yl)-n-(sec-butyl)penta-2,4-dienamide
C16H19NO3 (273.13648639999997)
3-{[1-(acetyloxy)-3-methylpentan-2-yl]-c-hydroxycarbonimidoyl}-3-methylpropanoic acid
4-[2-(dimethylamino)ethyl]-4-(4-methoxyphenyl)cyclohex-2-en-1-one
4-[(2-amino-3-hydroxyphenyl)methylidene]-5-(hydroxymethylidene)-3-methylideneheptan-2-one
C16H19NO3 (273.13648639999997)
(4z,5e)-4-[(2-amino-3-hydroxyphenyl)methylidene]-5-(hydroxymethylidene)-3-methylideneheptan-2-one
C16H19NO3 (273.13648639999997)
(3s,6s)-3-(hydroxymethyl)-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol
(2e,4z)-5-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)penta-2,4-dienimidic acid
C16H19NO3 (273.13648639999997)
n-{2-[hydroxy(nitroso)amino]-3-methylbutyl}octanimidic acid
C13H27N3O3 (273.20523119999996)
(1s,10r,12r)-4-methoxy-9-azatetracyclo[7.5.2.0¹,¹⁰.0²,⁷]hexadeca-2(7),3,5,13-tetraene-5,12-diol
C16H19NO3 (273.13648639999997)
(2e,4e)-5-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)penta-2,4-dienimidic acid
C16H19NO3 (273.13648639999997)
3-[(2s)-2-hydroxy-3-methylbut-3-en-1-yl]-4-methoxy-1-methylquinolin-2-one
C16H19NO3 (273.13648639999997)
(2e)-3-(2h-1,3-benzodioxol-5-yl)-1-(4-methylpiperidin-1-yl)prop-2-en-1-one
C16H19NO3 (273.13648639999997)
6-(4-methoxyphenyl)-n-(2-methylpropyl)hexa-3,5-dienimidic acid
(1s,2s,13r,15r)-2-hydroxy-15-methyl-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadeca-7,9-diene-11,12-dione
C16H19NO3 (273.13648639999997)
(z)-(hydroxyimino)({1-[(1-hydroxyoctylidene)amino]-3-methylbutan-2-yl})oxidoazanium
C13H27N3O3 (273.20523119999996)
(4s)-4-[2-(dimethylamino)ethyl]-4-(4-methoxyphenyl)cyclohex-2-en-1-one
4,8-dimethoxy-3-(3-methylbut-2-en-1-yl)quinolin-2-ol
C16H19NO3 (273.13648639999997)
3-(3-hydroxy-3-methylbut-1-en-1-yl)-4-methoxy-1-methylquinolin-2-one
C16H19NO3 (273.13648639999997)
(1s,2r,4r,8s,9r,11s)-8-[(1e,3e,5e)-5-methylhepta-1,3,5-trien-1-yl]-3-oxa-7-azatetracyclo[5.4.0.0²,⁴.0⁹,¹¹]undecan-1-ol
(2r)-1-(1h-indol-3-yl)-4-methyl-3-oxopentan-2-yl acetate
C16H19NO3 (273.13648639999997)
(1s,12s,14s)-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-ol
C16H19NO3 (273.13648639999997)
8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-phenylpropanoate
5-{[2-(4-hydroxyphenyl)ethyl](methyl)amino}-2-methoxyphenol
C16H19NO3 (273.13648639999997)
n-[2-(2,2-dimethylchromen-6-yl)ethyl]butanimidic acid
(2e,4e)-5-(2h-1,3-benzodioxol-5-yl)-n-[(2s)-butan-2-yl]penta-2,4-dienimidic acid
C16H19NO3 (273.13648639999997)
6-(4-methoxyphenyl)-n-(2-methylpropyl)hexa-2,4-dienimidic acid
(2e,8e)-7-hydroxy-n-(2-methylpropyl)trideca-2,8-dien-10,12-diynimidic acid
5-(2h-1,3-benzodioxol-5-yl)-n-(2-methylpropyl)penta-2,4-dienamide
C16H19NO3 (273.13648639999997)
(1s,7r,16r)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2,12,14-trien-4-one
C16H19NO3 (273.13648639999997)
3-(2-hydroxy-3-methylbut-3-en-1-yl)-4-methoxy-1-methylquinolin-2-one
C16H19NO3 (273.13648639999997)
1-[6-(2-hydroxy-2-phenylethyl)-1-methyl-5,6-dihydro-2h-pyridin-2-yl]propan-2-one
(2e)-3-(2h-1,3-benzodioxol-5-yl)-n-cyclohexylprop-2-enimidic acid
C16H19NO3 (273.13648639999997)